ACADIA Pharmaceuticals Inc.
Hedge Funds Holdings
Last updated:
ACADIA Pharmaceuticals Inc.‘s stocks are currently a part of 144 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 48.52M shares of ACADIA Pharmaceuticals Inc.. Compared to the previous quarter, the number fell by -68.83% or -107.13M shares fewer. As for the holding position changes, 29.17% (42) of current hedge fund investors increased the number of shares held, 30.56% (44) of current holders sold a part of the shares held, and 11.11% (16) closed the holdings completely. 22 hedge funds are new holders of ACADIA Pharmaceuticals Inc. stock in Q1 2023, it is 15.28% of total holders.
Hedge funds holding ACADIA Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 182 |
|---|---|
| Q3 2018 | 182 |
| Q4 2018 | 182 |
| Q1 2019 | 198 |
| Q2 2019 | 194 |
| Q3 2019 | 231 |
| Q4 2019 | 272 |
| Q1 2020 | 245 |
| Q2 2020 | 298 |
| Q3 2020 | 264 |
| Q4 2020 | 302 |
| Q1 2021 | 265 |
| Q2 2021 | 239 |
| Q3 2021 | 230 |
| Q4 2021 | 244 |
| Q1 2022 | 258 |
| Q2 2022 | 239 |
| Q3 2022 | 217 |
| Q4 2022 | 220 |
| Q1 2023 | 144 |
Hedge funds changes in ACADIA Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 40 | 62 | 56 | 50 | -26 |
|---|---|---|---|---|---|
| Q3 2018 | 39 | 55 | 56 | 39 | -7 |
| Q4 2018 | 36 | 65 | 54 | 35 | -8 |
| Q1 2019 | 36 | 72 | 60 | 21 | 9 |
| Q2 2019 | 30 | 53 | 75 | 30 | 6 |
| Q3 2019 | 64 | 73 | 66 | 27 | 1 |
| Q4 2019 | 71 | 96 | 78 | 27 | 0 |
| Q1 2020 | 35 | 87 | 83 | 59 | -19 |
| Q2 2020 | 80 | 81 | 94 | 26 | 17 |
| Q3 2020 | 52 | 102 | 86 | 81 | -57 |
| Q4 2020 | 73 | 93 | 95 | 32 | 9 |
| Q1 2021 | 45 | 107 | 83 | 79 | -49 |
| Q2 2021 | 38 | 86 | 72 | 65 | -22 |
| Q3 2021 | 29 | 76 | 80 | 37 | 8 |
| Q4 2021 | 43 | 68 | 94 | 26 | 13 |
| Q1 2022 | 45 | 79 | 83 | 28 | 23 |
| Q2 2022 | 34 | 70 | 85 | 50 | 0 |
| Q3 2022 | 23 | 78 | 66 | 48 | 2 |
| Q4 2022 | 28 | 74 | 77 | 22 | 19 |
| Q1 2023 | 22 | 42 | 44 | 16 | 20 |
Hedge funds changes in ACADIA Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 47,162,000 | 39,644,000 |
|---|---|---|
| Q3 2018 | 65,188,000 | 47,286,000 |
| Q4 2018 | 27,113,000 | 25,737,000 |
| Q1 2019 | 33,040,000 | 27,835,000 |
| Q2 2019 | 38,752,000 | 112,658,000 |
| Q3 2019 | 79,517,000 | 52,675,000 |
| Q4 2019 | 83,736,000 | 85,003,000 |
| Q1 2020 | 39,830,000 | 40,257,000 |
| Q2 2020 | 39,175,000 | 44,531,000 |
| Q3 2020 | 33,021,000 | 44,703,000 |
| Q4 2020 | 55,415,000 | 44,641,000 |
| Q1 2021 | 42,741,000 | 101,693,000 |
| Q2 2021 | 45,473,000 | 16,386,000 |
| Q3 2021 | 20,636,438 | 8,232,000 |
| Q4 2021 | 85,932,000 | 16,349,000 |
| Q1 2022 | 35,605,000 | 17,330,000 |
| Q2 2022 | 25,281,000 | 17,401,000 |
| Q3 2022 | 11,240,000 | 7,414,000 |
| Q4 2022 | 11,331,256 | 4,003,352 |
| Q1 2023 | 6,069,980,000 | 1,234,825,000 |